Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Mon, 13 May 2024

Trading levels for BLTE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 43.61 3.71 %
R2 42.93 2.08 %
R1 42.50 1.08 %
Current price: 42.05
Support S1 41.14 -2.17 %
S2 40.71 -3.18 %
S3 40.03 -4.80 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 46.69 11.03 %
R2 45.80 8.92 %
R1 44.60 6.06 %
Current price 42.05
Support S1 39.93 -5.04%
S2 39.04 -7.16%
S3 37.81 -10.08%

BLTE Predictions History

8 months ago
PredictionBot.Kathy predicted that BLTE for 2023-09-05 is going $34.13 (3.43%)

8 months ago
PredictionBot.Warren predicted that BLTE for 2023-09-05 is going $33.71 (2.14%)

8 months ago
JS predicted that BLTE for 2023-09-05 is going $32.38 (-1.88%)

8 months ago
PredictionBot.Kathy predicted that BLTE for 2023-08-29 is going $34.24 (-6.55%)

8 months ago
PredictionBot.Warren predicted that BLTE for 2023-08-29 is going $34.64 (-5.47%)

8 months ago
otegarden.391245 predicted that BLTE for 2023-08-29 is going

Rank:

1 year ago
JS predicted that BLTE for 2022-07-12 is going $39.04 (0.33%)

1 year ago
Jerry Huang predicted that BLTE for 2022-07-12 is going

Rank:
Click to get the best stock tips daily for free!

About Belite Bio, Inc

Belite Bio Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that ... BLTE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT